3 Results for "

bone marrow microenvironment

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "bone marrow microenvironment" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99039
CAS No.: 1803176-05-7
Synonyms: MEDI9447

Target:  

CD73

Research Areas:  

Cancer

Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-153358
CAS No.: 2935964-98-8
Purity:  99.91%
Target:  

HDAC

Research Areas:  

Cancer

TNG260 is a selective, orally effective inhibitor of HDAC1 and CoREST complex, with a 10-fold selectivity for HDAC1 over HDAC3 and a 500-fold selectivity for CoREST complex over NuRD and Sin3 complex. TNG260 reshapes the tumor immune microenvironment, reduces immunosuppressive neutrophil infiltration, promotes effector T cell recruitment, and reverses anti-PD-1 resistance caused by STK11 deficiency by inhibiting the activity of the CoREST-HDAC1 complex. TNG260 induces durable tumor regression in combination with α-PD1 in MC38 tumor-bearing mice with STK11 mutations, and has lower toxicity to bone marrow cells than non-selective HDAC inhibitors .
loading...
    loading...
Cat. No.: HY-173070
CAS No.: 2275612-76-3
TLR7 agonist 29 (Compound 1) is the agonist for TLR7 with an EC50 of 5.2 nM for human TLR7 (EC50 for mouse TLR7 is 48.2 nM). TLR7 agonist 29 activates bone marrow-derived macrophages (BMDMs), stimulates myeloid cells in the tumor microenvironment, promotes the expression of PD-L1, CD86 and IFN-α. TLR7 agonist 29 can be used as payload for synthesis of ADC .
loading...
    loading...